Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos

Translated title of the contribution: Diagnosis and Treatment of Drug-Resistant Tuberculosis

José A. Caminero, Joan A. Cayla, José María García-García, Francisco J. García-Pérez, Juan J. Palacios, Juan Ruiz-Manzano

Research output: Contribution to journalArticle

Abstract

In the last 2 decades, drug-resistant tuberculosis has become a threat and a challenge to worldwide public health. The diagnosis and treatment of these forms of tuberculosis are much more complex and prognosis clearly worsens as the resistance pattern intensifies. Nevertheless, it is important to remember that with the appropriatesystematic clinical management, most of these patients can be cured. These guidelines itemize the basis for the diagnosis and treatment of all tuberculosis patients, from those infected by strains that are sensitive to all drugs, to those who are extensively drug-resistant. Specific recommendations are given forall cases. The current and future role of new molecular methods for detecting resistance, shorter multi-drug-resistant tuberculosis regimens, and new drugs with activity against Mycobacterium tuberculosis are also addressed.

Original languageSpanish
Pages (from-to)501-509
Number of pages9
JournalArchivos de Bronconeumologia
Volume53
Issue number9
DOIs
StatePublished - Sep 1 2017
Externally publishedYes

Fingerprint

Multidrug-Resistant Tuberculosis
Tuberculosis
Pharmaceutical Preparations
Mycobacterium tuberculosis
Therapeutics
Public Health
Guidelines

Keywords

  • Diagnosis
  • Drug-resistant tuberculosis
  • Extremely drug-resistant tuberculosis
  • Multi-drug-resistant tuberculosis
  • Treatment

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Caminero, J. A., Cayla, J. A., García-García, J. M., García-Pérez, F. J., Palacios, J. J., & Ruiz-Manzano, J. (2017). Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos. Archivos de Bronconeumologia, 53(9), 501-509. https://doi.org/10.1016/j.arbr.2017.07.005

Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos. / Caminero, José A.; Cayla, Joan A.; García-García, José María; García-Pérez, Francisco J.; Palacios, Juan J.; Ruiz-Manzano, Juan.

In: Archivos de Bronconeumologia, Vol. 53, No. 9, 01.09.2017, p. 501-509.

Research output: Contribution to journalArticle

Caminero, JA, Cayla, JA, García-García, JM, García-Pérez, FJ, Palacios, JJ & Ruiz-Manzano, J 2017, 'Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos', Archivos de Bronconeumologia, vol. 53, no. 9, pp. 501-509. https://doi.org/10.1016/j.arbr.2017.07.005
Caminero JA, Cayla JA, García-García JM, García-Pérez FJ, Palacios JJ, Ruiz-Manzano J. Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos. Archivos de Bronconeumologia. 2017 Sep 1;53(9):501-509. https://doi.org/10.1016/j.arbr.2017.07.005
Caminero, José A. ; Cayla, Joan A. ; García-García, José María ; García-Pérez, Francisco J. ; Palacios, Juan J. ; Ruiz-Manzano, Juan. / Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos. In: Archivos de Bronconeumologia. 2017 ; Vol. 53, No. 9. pp. 501-509.
@article{2a268abb631d4c088779f4b236e22313,
title = "Diagn{\'o}stico y tratamiento de la tuberculosis con resistencia a f{\'a}rmacos",
abstract = "In the last 2 decades, drug-resistant tuberculosis has become a threat and a challenge to worldwide public health. The diagnosis and treatment of these forms of tuberculosis are much more complex and prognosis clearly worsens as the resistance pattern intensifies. Nevertheless, it is important to remember that with the appropriatesystematic clinical management, most of these patients can be cured. These guidelines itemize the basis for the diagnosis and treatment of all tuberculosis patients, from those infected by strains that are sensitive to all drugs, to those who are extensively drug-resistant. Specific recommendations are given forall cases. The current and future role of new molecular methods for detecting resistance, shorter multi-drug-resistant tuberculosis regimens, and new drugs with activity against Mycobacterium tuberculosis are also addressed.",
keywords = "Diagnosis, Drug-resistant tuberculosis, Extremely drug-resistant tuberculosis, Multi-drug-resistant tuberculosis, Treatment",
author = "Caminero, {Jos{\'e} A.} and Cayla, {Joan A.} and Garc{\'i}a-Garc{\'i}a, {Jos{\'e} Mar{\'i}a} and Garc{\'i}a-P{\'e}rez, {Francisco J.} and Palacios, {Juan J.} and Juan Ruiz-Manzano",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.arbr.2017.07.005",
language = "Spanish",
volume = "53",
pages = "501--509",
journal = "Archivos de Bronconeumologia",
issn = "0300-2896",
publisher = "Ediciones Doyma, S.L.",
number = "9",

}

TY - JOUR

T1 - Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos

AU - Caminero, José A.

AU - Cayla, Joan A.

AU - García-García, José María

AU - García-Pérez, Francisco J.

AU - Palacios, Juan J.

AU - Ruiz-Manzano, Juan

PY - 2017/9/1

Y1 - 2017/9/1

N2 - In the last 2 decades, drug-resistant tuberculosis has become a threat and a challenge to worldwide public health. The diagnosis and treatment of these forms of tuberculosis are much more complex and prognosis clearly worsens as the resistance pattern intensifies. Nevertheless, it is important to remember that with the appropriatesystematic clinical management, most of these patients can be cured. These guidelines itemize the basis for the diagnosis and treatment of all tuberculosis patients, from those infected by strains that are sensitive to all drugs, to those who are extensively drug-resistant. Specific recommendations are given forall cases. The current and future role of new molecular methods for detecting resistance, shorter multi-drug-resistant tuberculosis regimens, and new drugs with activity against Mycobacterium tuberculosis are also addressed.

AB - In the last 2 decades, drug-resistant tuberculosis has become a threat and a challenge to worldwide public health. The diagnosis and treatment of these forms of tuberculosis are much more complex and prognosis clearly worsens as the resistance pattern intensifies. Nevertheless, it is important to remember that with the appropriatesystematic clinical management, most of these patients can be cured. These guidelines itemize the basis for the diagnosis and treatment of all tuberculosis patients, from those infected by strains that are sensitive to all drugs, to those who are extensively drug-resistant. Specific recommendations are given forall cases. The current and future role of new molecular methods for detecting resistance, shorter multi-drug-resistant tuberculosis regimens, and new drugs with activity against Mycobacterium tuberculosis are also addressed.

KW - Diagnosis

KW - Drug-resistant tuberculosis

KW - Extremely drug-resistant tuberculosis

KW - Multi-drug-resistant tuberculosis

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85027225177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027225177&partnerID=8YFLogxK

U2 - 10.1016/j.arbr.2017.07.005

DO - 10.1016/j.arbr.2017.07.005

M3 - Article

VL - 53

SP - 501

EP - 509

JO - Archivos de Bronconeumologia

JF - Archivos de Bronconeumologia

SN - 0300-2896

IS - 9

ER -